Cadrenal Therapeutics, Inc. (CVKD) Free cash flow 2023–2025
Cadrenal Therapeutics, Inc. (CVKD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$12.6MFY2025 · since FY2023: -$3.5M → -$12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.6M | -71.2% |
| FY2024 | -$7.4M | -108.4% |
| FY2023 | -$3.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CVKD financial trends
CVKD RevenueCVKD Net incomeCVKD Net marginCVKD Gross profitCVKD Gross marginCVKD Operating incomeCVKD Operating marginCVKD Operating cash flowCVKD Capital expendituresCVKD Return on equityCVKD Stock buybacksCVKD Dividends paidCVKD Total assetsCVKD Total liabilitiesCVKD Shareholders’ equityCVKD overview →